REGENERATIVE MEDICAL TECHNOLOGY GROUP INC.

Regenerative Medical Technology Group Inc.

Equities

MSSV

US59071L1035

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 11:25:27 02/07/2024 pm IST			5-day change	1st Jan Change
0.0442 ^USD	+10.55%		+26.29%	+505.48%

20/05	Regenerative Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/04	Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Oriens Travel and Hotel Management Corp. cancelled the acquisition of the assets of Hundley Associates Costa Rica SRL.

January 24, 2015 at 09:30 am IST

Oriens Travel and Hotel Management Corp. (OTCPK:OTHM) entered into an letter of intent to acquire the assets of Hundley Associates Costa Rica SRL on January 24, 2014. As of July 6, 2014, the transaction has been put on hold for the time being.

Oriens Travel and Hotel Management Corp. (OTCPK:OTHM) cancelled the acquisition of the assets of Hundley Associates Costa Rica SRL on January 24, 2015.

Latest news about Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	21/05	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04	CI
Meso Numismatics, Inc. will Change its Name to Regenerative Medical Technology Group Inc	04/03	CI
Meso Numismatics, Inc. Announces New Clinics	31/01	CI
Meso Numismatics, Inc. Reports Sales Results for the Year 2023	31/01	CI
Meso Numismatics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	31/01	CI
Meso Numismatics, Inc. announced that it expects to receive $10 million in funding from GHS Investments, LLC	08/12	CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/23/22	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
Meso Numismatics, Inc. Auditor Raises 'Going Concern' Doubt	14/23/14	CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/22/09	CI
Meso Numismatics, Inc.'s Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX	28/22/28	CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Meso Numismatics, Inc. Expands its Stem Cell Therapy and Regenerative Medicine Centers to Indonesia	01/22/01	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/22/20	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	05/22/05	CI
Meso Numismatics, Inc. Auditor Raises 'Going Concern' Doubt	05/22/05	CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22/21/22	CI
Meso Numismatics, Inc. completed the acquisition of Global Stem Cells Group, Inc. from Benito Novas.	18/21/18	CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14/21/14	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/21/17	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	13/21/13	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	07/21/07	CI

Chart Regenerative Medical Technology Group Inc.

Duration

Period

Chart Regenerative Medical Technology Group Inc.

More charts

Company Profile

Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
REGENERATIVE MEDICAL TECHNOLOGY GROUP INC.	+505.48%	552K
MODERNA, INC.	+16.59%	44.87B
IQVIA HOLDINGS INC.	-10.62%	37.8B
LONZA GROUP AG	+40.49%	37.61B
ALNYLAM PHARMACEUTICALS, INC.	+29.92%	31.32B
CELLTRION, INC.	-9.78%	27.4B
ICON PUBLIC LIMITED COMPANY	+12.34%	26.32B
UNITED THERAPEUTICS CORPORATION	+41.53%	14.07B
MEDPACE HOLDINGS, INC.	+31.49%	12.5B
BIO-TECHNE CORPORATION	-7.40%	11.23B

Other Biotechnology & Medical Research